BETHLEHEM, Pa., April 13, 2016 -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 first quarter financial results, 2016 second quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 4, 2016.
| May 4, 2016 Schedule | ||
| 4:00 p.m. ET | 2016 first quarter financial results will be distributed | |
| by GlobeNewswire | ||
| 4:50 p.m. ET | To participate in the conference call, dial 844-831-3030 (Domestic) | |
| or 315-625-6887 (International) and reference Conference | ||
| ID # 83627952. | ||
| 5:00 p.m. ET | Conference call and simultaneous Webcast begins | |
The conference call will also be webcast live and may be accessed on the Investor Relations page of OraSure’s website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access 10 minutes prior to the call.
If you are unable to participate, a replay of the call will be archived on OraSure’s website shortly after the call has ended and will be available for seven days. A replay of the call can also be accessed until midnight, May 11, 2016 by dialing 855-859-2056 (Domestic) or 404-537-3406 (International) and entering the Conference ID #83627952.
COMPANY CONTACT: Rena George-Beck, OraSure Technologies, Inc. 610-882-1820, or [email protected].


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



